Back to results
US 2026/0130919 A1Published application
Pralatrexate and cop combination for the treatment of patients with peripheral t cell lymphoma
AssigneeAcrotech Biopharma Inc.
InventorAshish Anvekar
Life of this patent
Estimating the term…
Abstract
The disclosure provides compositions and methods for treating peripheral T-cell lymphoma (PTCL) using a combination of Pralatrexate and COP.
Claims23
A method for treating peripheral T-cell lymphoma (PTCL) comprising administering to a subject in need thereof a combination comprising Cyclophosphamide, Vincristine, Prednisone and Pralatrexate,
- wherein the combination does not comprise doxorubicin.
A kit comprising Pralatrexate, Cyclophosphamide, Vincristine, and Prednisone, wherein said kit does not comprise doxorubicin.
18-20. (canceled)
(canceled)
25-27. (canceled)
Dependencies are inferred from the claim text.